Biomedical catalyst 2017 round 3: feasibility studies
Micro, small or medium-size UK companies can apply for a share of £2 million to work alone or with others on solving healthcare challenges.
The aim of this competition is to support the development of innovative healthcare technologies and processes. These may include:
- disease prevention and proactive management of health and chronic conditions
- earlier and better detection and diagnosis of disease, leading to better patient outcomes
- tailored treatments that either change the underlying disease or offer potential cures
The biomedical catalyst has 4 types of funding award designed to support small to medium enterprises (SMEs) that are developing a product or process. It helps them progress from initial concept through to late-stage development.
Each type of award has a different scope. You should apply only if your project fits a specific competition scope.
This is a feasibility competition. They are looking to fund projects that explore and evaluate the commercial potential of innovative scientific ideas by:
- reviewing research evidence and identifying possible applications
- assessing business opportunities
- investigating the intellectual property position
- validating initial concepts or existing pre-clinical work through experimental studies
identifying areas for further development
They expect projects to range in size up to £200,000. Projects should last no longer than 12 months.
You can find out more on the competition page here.